Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC
Business

Listen to this article

0%

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the c… [+2675 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected